 | |||||||||||||||
 |
 |
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
 |
News item posted on 2016-04-08
Research Spotlight - Jens Meiler
CSB Researcher Jens Meiler, Ph.D., and Vanderbilt colleague James Crowe, Jr., M.D. led a study isolating antibodies that binds tightly to HIV and disables it – even in people not infected by the virus.
The findings, published in Proceedings of the National Academy of Sciences, suggest it might be possible to use a structure-based vaccine design approach to induce neutralizing antibodies against HIV in people who have not previously been exposed to the virus.
The research demonstrates an increased chance that a large proportion of the vaccinated population could respond to HIV with a broad and potent antibody response.
Read the complete article online at Research News @ Vanderbilt.
Author: Karen D. Davis